Evidence map›Paper›PMID 38717632›Full record

ArticleCardiovascular research2025

Oxidative DNA damage promotes vascular ageing associated with changes in extracellular matrix-regulating proteins.

Kirsty Foote, Marieke Rienks, Lukas Schmidt, Konstantinos Theofilatos, Yasmin, Matiss Ozols, Alexander Eckersley, Aarti Shah, Nichola Figg, Alison Finigan and 4 more

Abstract read
In one paragraph

Article in Cardiovascular research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Enzymatic and non-enzymatic oxidation of fibrillar collagen.Redox report : communications in free radical research · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Microvascular Health as a Key Determinant of Organismal Aging.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  9. Review
  10. Review
  11. Acetyltransferase in cardiovascular disease and aging.The journal of cardiovascular aging · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kirsty FooteSection of Cardiorespiratory Medicine, University of Cambridge, Victor Phillip Dahdaleh Heart & Lung Research Institute, Papworth Road, Cambridge Biomedical Campus, Cambridge CB2 0BB, UK.
Marieke RienksCardiovascular Division, King's College London, The James Black Centre, 2nd Floor, 125 Coldharbour Lane, London SE5 9NU, UK.
Lukas SchmidtCardiovascular Division, King's College London, The James Black Centre, 2nd Floor, 125 Coldharbour Lane, London SE5 9NU, UK.
Konstantinos TheofilatosCardiovascular Division, King's College London, The James Black Centre, 2nd Floor, 125 Coldharbour Lane, London SE5 9NU, UK.ORCID 0000-0001-6799-0553
YasminDepartment of Medicine, Experimental Medicine and Therapeutics, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 2QQ, UK.ORCID 0000-0002-5478-7123
Matiss OzolsHuman Genetics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Saffron Walden CB10 1RQ, UK.
Alexander EckersleyDivision of Musculoskeletal & Dermatological Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK.
Aarti ShahSection of Cardiorespiratory Medicine, University of Cambridge, Victor Phillip Dahdaleh Heart & Lung Research Institute, Papworth Road, Cambridge Biomedical Campus, Cambridge CB2 0BB, UK.
Nichola FiggSection of Cardiorespiratory Medicine, University of Cambridge, Victor Phillip Dahdaleh Heart & Lung Research Institute, Papworth Road, Cambridge Biomedical Campus, Cambridge CB2 0BB, UK.
Alison FiniganSection of Cardiorespiratory Medicine, University of Cambridge, Victor Phillip Dahdaleh Heart & Lung Research Institute, Papworth Road, Cambridge Biomedical Campus, Cambridge CB2 0BB, UK.ORCID 0000-0003-4252-9474
Kevin O'ShaughnessyDepartment of Medicine, Experimental Medicine and Therapeutics, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 2QQ, UK.
Ian WilkinsonDepartment of Medicine, Experimental Medicine and Therapeutics, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 2QQ, UK.
Manuel MayrCardiovascular Division, King's College London, The James Black Centre, 2nd Floor, 125 Coldharbour Lane, London SE5 9NU, UK.
Martin BennettSection of Cardiorespiratory Medicine, University of Cambridge, Victor Phillip Dahdaleh Heart & Lung Research Institute, Papworth Road, Cambridge Biomedical Campus, Cambridge CB2 0BB, UK.ORCID 0000-0002-2565-1825

Funding

Biomedical Research Centre NIHR203312British Heart Foundation CH/2000003/12800British Heart Foundation PG/13/25/30014British Heart Foundation PG/16/11/32021British Heart Foundation PG/22/10944Department of Health and Social CareRosetrees Trust CM374
6 · The paper itself

Abstract

aimsVascular ageing is characterized by vessel stiffening, with increased deposition of extracellular matrix (ECM) proteins including collagens. Oxidative DNA damage occurs in vascular ageing, but how it regulates ECM proteins and vascular stiffening is unknown. We sought to determine the relationship between oxidative DNA damage and ECM regulatory proteins in vascular ageing. METHODS AND

resultsWe examined oxidative DNA damage, the major base excision repair (BER) enzyme 8-Oxoguanine DNA Glycosylase (Ogg1) and its regulators, multiple physiological markers of ageing, and ECM proteomics in mice from 22 to 72 w. Vascular ageing was associated with increased oxidative DNA damage, and decreased expression of Ogg1, its active acetylated form, its acetylation regulatory proteins P300 and CBP, and the transcription factor Foxo3a. Vascular stiffness was examined in vivo in control, Ogg1-/-, or mice with vascular smooth muscle cell-specific expression of Ogg1+ (Ogg1) or an inactive mutation (Ogg1KR). Ogg1-/- and Ogg1KR mice showed reduced arterial compliance and distensibility, and increased stiffness and pulse pressure, whereas Ogg1 expression normalized all parameters to 72 w. ECM proteomics identified major changes in collagens with ageing, and downregulation of the ECM regulatory proteins Protein 6-lysyl oxidase (LOX) and WNT1-inducible-signaling pathway protein 2 (WISP2). Ogg1 overexpression upregulated LOX and WISP2 both in vitro and in vivo, and downregulated Transforming growth factor β1 (TGFb1) and Collagen 4α1 in vivo compared with Ogg1KR. Foxo3a activation induced Lox, while Wnt3 induction of Wisp2 also upregulated LOX and Foxo3a, and downregulated TGFβ1 and fibronectin 1. In humans, 8-oxo-G increased with vascular stiffness, while active OGG1 reduced with both age and stiffness.

conclusionVascular ageing is associated with oxidative DNA damage, downregulation of major BER proteins, and changes in multiple ECM structural and regulatory proteins. Ogg1 protects against vascular ageing, associated with changes in ECM regulatory proteins including LOX and WISP2.

Indexed as

AgingDNA DamageExtracellular MatrixExtracellular Matrix ProteinsMuscle, Smooth, VascularMyocytes, Smooth MuscleOxidative StressVascular StiffnessAcetylationAnimalsCells, CulturedDNA GlycosylasesForkhead Box Protein O3HumansMaleMiceDNA GlycosylasesExtracellular Matrix ProteinsForkhead Box Protein O3FoxO3 protein, mouseOgg1 protein, mouseAgeingDNA damageExtracellular matrix

Identifiers

PMID38717632
PMCPMC12054627

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.